Neuland Laboratories, a pharmaceutical manufacturer, said that the board of directors has allotted 10,700 fully paid up equity shares of a face value of R. 10 each, to eligible employees pursuant to exercise of stock options granted under Employee Stock Option Scheme, 2008.
Consequently, the paid-up equity capital of the company stands increased to Rs 7,65,56,780 from Rs 7,64,49,780 with effect from Jan. 21, 2014.
Shares of the company declined Rs 1.8, or 0.58%, to settle at Rs 311. The total volume of shares traded was 756 at the BSE (Tuesday).